Clinical Trial Update: The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated the effects of atomoxetine on cognition and brain function in individuals with schizophrenia and memory/cognitive disorders, with o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Disorders
• Memory Disorders
• Schizophrenia

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Schizophrenia, Memory Disorders | Phase 2 | Status: TERMINATED | Results posted: 2013-06-14